Skip to main content

Newsroom

Latest News

April 7, 2019

"We believe it is necessary to the goal of collecting actual emissions data and working with real numbers, rather than models or estimates." Brian Cain, Extraction Oil and Gas spokesman

April 7, 2019

Colorado public health officials routinely allow oil and gas companies to begin drilling and fracking without obtaining federally required permits that limit the amount of pollution they can discharge into the air.

April 5, 2019
No one in this country should have to choose between paying their rent or paying for their life-saving medication. So, this week, I continued to work on the important issue of bringing down the cost of insulin.
April 5, 2019

WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Jackie Speier (D-CA) introduced legislation today to overhaul the U.S. military's policy on providing servicemembers and their families with family-planning counseling services and coverage for contraceptives.

April 2, 2019

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that's investigating the skyrocketing cost of insulin, announced today that all three U.S. manufacturers of insulin will be appearing before Congress next week.

April 2, 2019

WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO), Mark DeSaulnier (D-CA), Zoe Lofgren (D-CA) and Jamie Raskin (D-MD) introduced a resolution today to recognize the vital role that local journalists play in promoting good governance and accountability.

April 2, 2019

The only three companies that manufacture insulin in the United States will testify in the House next week about their pricing practices.

Rep. Diana DeGette (D-Colo.), chairwoman of the House Energy and Commerce oversight subcommittee, said the three companies— Eli Lilly, Novo Nordisk and Sanofi— will testify April 10.

April 2, 2019

U.S. Representative Diana DeGette's bill to halt federal marijuana prohibition in states where cannabis is legal was introduced on Monday, April 1, but she insists the issue is no joke.

April 1, 2019

Colorado's Rep. Diana DeGette, representing the 1st Congressional District, introduced a bill aimed at bringing down the cost of insulin. The bill would make permanent a new FDA policy which would speed up the approval of generic version of certain drugs.

That would include insulin.

DeGette met with Colorado patients to talk about their struggle the cost of insulin.

April 1, 2019

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) introduced legislation today that would prevent the federal government from enforcing its prohibition on marijuana in states, such as Colorado, where it is legal for residents to possess and use the drug.